Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche and PTC sign CNS research deal

September 4, 2009
Research and Development CNS, Roche

 PTC Therapeutics has signed an early-stage drug discovery deal with Roche that will focus on treatments for central nervous system …

News

Cameron: Tories are ‘the party of the NHS’

September 4, 2009
NHS, US

David Cameron has called the Conservatives the "party of the NHS," in an attempt to reassure voters the service is …

News

Head-to-head boost for Brilinta over Plavix

September 4, 2009
Research and Development, Sales and Marketing AZ, Brillinta

 AstraZeneca has released details of its brand Brilinta’s performance in head-to-head trials with Plavix, the world’s second biggest-selling drug.Earlier this …

News

Roche’s MabThera expands licence in leukaemia

September 4, 2009
Research and Development, Sales and Marketing MabThera, Roche

 MabThera has been approved in Europe for use in previously treated chronic lymphocytic leukaemia, which Roche says will offer new …

News

Merck launches Saflutan in first European markets

September 4, 2009
Research and Development, Sales and Marketing Merck, ophthalmology

Merck's glaucoma drug Saflutan has been launched in the UK and Spain. The manufacturer says more launches are planned in …

News

Novartis swine-flu jab effective in single dose

September 3, 2009
Manufacturing and Production, Research and Development, Sales and Marketing Novartis, h1n1

A study of Novartis' pandemic swine-flu jab shows it is potentially protective after just one dose, which could help eke …

News

Pharmafocus expands into Europe

September 3, 2009
Research and Development, Sales and Marketing Europe

 The September issue of Pharmafocus marks a new stage in the publication’s development with an expanded monthly circulation that takes …

News

Merck unveils post-merger leadership team

September 3, 2009
Research and Development, Sales and Marketing MA, Merck

The make-up of Merck and Schering-Plough's new corporate entity became clearer this week. Referred to as the 'new Merck' and …

News

Pfizer shamed with $2.3bn fine for marketing fraud

September 3, 2009
Sales and Marketing Pfizer, US, illegal, off label prescribing

The US government has imposed a $2.3 billion fine on Pfizer for a string of offences including illegal off-label prescribing …

News

New cancer cases set to hit 17 million by 2020

September 2, 2009
Research and Development, Sales and Marketing Cancer, healthcare

The next ten years will see a 30% leap in the number of new cancer cases across the world, according …

News

Pandemic planning: GSK’s Dr Neil Formica

September 1, 2009
Research and Development GlaxoSmithKline, Vaccine, h1n1

 

Feature

UCB and Novartis expand alliance in Germany

September 1, 2009
Sales and Marketing Germany, Novartis, UCB

UCB and Novartis have extended their partnership in Germany with a new licensing deal for the cardiovascular and diabetes drug …

News

Shire goes for early approval in Gaucher disease

September 1, 2009
Research and Development, Sales and Marketing Gaucher's, Shire

Shire has filed for early US approval of its Gaucher disease drug velaglucerase alfa, as supplies to Genzyme's established rival …

News

Pradaxa data boosts Boehringer

September 1, 2009
Research and Development, Sales and Marketing Boehringer, Pradaxa

Boehringer Ingelheim has unveiled new positive data for its blood-thinner Pradaxa, showing it reduces the risk of stroke compared to …

News

Pfizer agrees price cut in Clinton deal

September 1, 2009
Research and Development, Sales and Marketing HIV, Pfizer, price cuts

Former US President Bill Clinton has brokered major new deals with Pfizer and Mylan to cut the price of tuberculosis …

News

Indian government accepts pro-patent report

September 1, 2009
Research and Development, Sales and Marketing Asia, India, patents

The government of India has accepted the findings of a report into its patent laws, which recommends maintaining a higher …

News

EU divided over patient information proposals

September 1, 2009
Sales and Marketing EFPIA, Europe, patient information

 Europe’s member states are at loggerheads over plans to relax current restrictions on pharma communicating with patients.The plans tabled by …

News

Basilea buoyed by sales increase

September 1, 2009
Research and Development, Sales and Marketing Basilea

Swiss pharma company Basilea Pharmaceutica has unveiled encouraging interim financial results, showing it has doubled its sales and decreased its …

News

JLL says it will fight Lonza’s Patheon bid

September 1, 2009
Manufacturing and Production JLL, Patheon

Lonza's attempt to buy Canadian contract manufacturer Patheon will not go unopposed by private equity group JLL, which has been …

News

Supply chain controls blamed for UK medicines shortage

August 27, 2009
Manufacturing and Production, Research and Development supply chain

Industry supply chain controls in the UK have overwhelmingly made medicines more difficult to source and have put patients risk, …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026